Modification of depression by COMT val158met polymorphism in children exposed to early severe psychosocial deprivation.
OBJECTIVE
To examine the impact of the catechol-O-methyltransferase (COMT) val(158)met allele on depressive symptoms in young children exposed to early severe social deprivation as a result of being raised in institutions.


METHODS
One hundred thirty six children from the Bucharest Early Intervention Project (BEIP) were randomized before 31 months of age to either care as usual (CAU) in institutions or placement in newly created foster care (FCG). At 54 months of age, a psychiatric assessment using the Preschool Age Psychiatric Assessment (PAPA) was completed. DNA was collected and genotyped for the COMT val(158)met polymorphism. Multivariate analysis examined the relationship between COMT alleles and depressive symptoms.


RESULTS
Mean level of depressive symptoms was lower among participants with the met allele compared to those with two copies of the val allele (P<0.05). Controlling for group and gender, the rate of depressive symptoms was significantly lower among participants with the met/met or the met/val genotype [adjusted relative risk (aRR)=0.67, 95% CI=0.45, 0.99] compared to participants with the val/val genotype, indicating an intermediate impact for heterozygotes consistent with the biological impact of this polymorphism. The impact of genotype within groups differed significantly. There was a significant protective effect of the met allele on depressive symptoms within the CAU group, however there was no relationship seen within the FCG group.


CONCLUSIONS
This is the first study, to our knowledge, to find evidence of a genexenvironment interaction in the setting of early social deprivation. These results support the hypothesis that individual genetic differences may explain some of the variability in recovery amongst children exposed to early severe social deprivation.
Drury
Stacy S
SS
Tulane University Health Sciences Center, New Orleans, LA, USA.
Theall
Katherine P
KP
Smyke
Anna T
AT
Keats
Bronya J B
BJ
Egger
Helen L
HL
Nelson
Charles A
CA
Fox
Nathan A
NA
Marshall
Peter J
PJ
Zeanah
Charles H
CH
D001483:Base Sequence; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D002649:Child Abuse / Q000523:psychology*; D002675:Child, Preschool; D003865:Major Depressive Disorder / Q000453:epidemiology / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011110:Polymorphism, Genetic / Q000235:genetics*; D011610:Psychosocial Deprivation
D002394:Catechol O-Methyltransferase
Dev Psychopathol. 2008 Summer;20(3):861-80
18606035
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):935-8
16921496
Am J Psychiatry. 1997 Jan;154(1):113-5
8988970
J Dev Behav Pediatr. 2000 Jun;21(3):230-6
10883884
Cereb Cortex. 2007 Sep;17 Suppl 1:i161-70
17725999
Pharmacol Rev. 1975 Jun;27(2):135-206
1103160
Dev Psychopathol. 2005 Summer;17(3):621-39
16262985
Child Dev. 2009 Jul-Aug;80(4):1039-56
19630892
Am J Psychiatry. 2009 Jul;166(7):777-85
19487394
Science. 2007 Dec 21;318(5858):1937-40
18096809
Genes Brain Behav. 2005 Nov;4(8):466-81
16268991
Infant Ment Health J. 2006 Nov;27(6):581-583
28640368
Int Clin Psychopharmacol. 2002 Dec;17 Suppl 4:S1-7; discussion S7
12685916
JAMA. 2008 Mar 19;299(11):1291-305
18349090
J Pediatr. 2008 Sep;153(3):408-13
18534206
Science. 2006 Dec 22;314(5807):1930-3
17185601
J Speech Lang Hear Res. 2007 Oct;50(5):1365-81
17905917
Prog Brain Res. 1990;85:367-402; discussion 402-3
2094906
Dev Psychopathol. 2003 Fall;15(4):885-907
14984131
Neuroreport. 1998 May 11;9(7):1305-8
9631418
J Child Psychol Psychiatry. 2007 Feb;48(2):210-8
17300560
Behav Brain Funct. 2005 Oct 18;1:19
16232322
Science. 2003 Jul 18;301(5631):386-9
12869766
Am J Psychiatry. 1965 Nov;122(5):509-22
5319766
Biol Psychiatry. 1997 Aug 15;42(4):282-5
9270905
Mol Psychiatry. 2005 Jun;10(6):598-605
15583702
J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):538-549
16601400
Pharmacogenetics. 1996 Jun;6(3):243-50
8807664
J Nucl Med. 1996 Apr;37(4):554-9
8691238
J Cogn Neurosci. 2004 Oct;16(8):1327-38
15532128
Biol Psychiatry. 2006 Apr 15;59(8):673-80
16458264
Am J Med Genet B Neuropsychiatr Genet. 2004 Jul 1;128B(1):61-4
15211633
Am J Psychiatry. 2004 Jan;161(1):125-32
14702260
Child Dev. 2005 Jan-Feb;76(1):54-72
15693757
Psychol Bull. 2004 Jan;130(1):66-79
14717650
Child Dev. 1998 Aug;69(4):1092-106
9768488
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9991-6
9707588
J Child Psychol Psychiatry. 2006 Dec;47(12):1246-53
17176379
J Neurochem. 1994 Sep;63(3):972-9
7914228
Am J Psychiatry. 2002 Jan;159(1):23-9
11772685
Biochemistry. 1995 Apr 4;34(13):4202-10
7703232
J Clin Psychiatry. 2006;67 Suppl 6:3-8
16848670
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17316-21
15563601
J Child Psychol Psychiatry. 2009 Mar;50(3):246-53
19309327
Bipolar Disord. 2007 Jun;9(4):370-6
17547583
Infant Ment Health J. 2006 Nov;27(6):559-576
28640378
N Engl J Med. 1967 Jun 8;276(23):1271-8
6024346
Pediatrics. 2006 Jun;117(6):2093-100
16740852
Ann N Y Acad Sci. 1988;537:138-47
3059920
Mol Psychiatry. 1998 Jul;3(4):346-9
9702745
Neuroimage. 2001 Dec;14(6):1290-301
11707085
Mol Psychiatry. 1998 Jul;3(4):342-5
9702744
Mol Psychiatry. 2004 Oct;9(10):908-15
15241435